DALLAS, Feb. 11, 2014 — Deloitte Corporate Finance LLC (“DCF”) acted as the financial advisor to Kainos Capital, LLC (“Kainos”) in its acquisition of InterHealth Nutraceuticals, Inc. (“InterHealth”).
“DCF’s knowledge and experience in the nutritional supplement industry enabled us to better understand the complex landscape in which InterHealth operates. DCF’s leadership, experience and industry access were vital to accomplishing the transaction,” said Andrew Rosen, Managing Partner of Kainos Capital, LLC.
“The professionals at Kainos have extensive investment and operational experience in the food and beverage industry and have, in our opinion, identified another exceptional company to add to their portfolio. With the support and leadership of the Kainos team, InterHealth is expected to further penetrate its end markets and continue to strengthen its competitive position,” said Lorin DeMordaunt, managing director, Deloitte Corporate Finance LLC, and head of DCF’s consumer and retail group.
About Kainos Capital, LLC
Kainos Capital is a middle market private equity firm with an exclusive focus on the food and consumer sector. The Kainos team has extensive investment and operating experience in the industry, having invested more than $2 billion of equity in more than 40 transactions with a total transaction value in excess of $7 billion. The firm’s strategy is to build a diversified portfolio of growing and strategically relevant food and consumer businesses that trade buyers would like to acquire. For more information, visit Kainos Capital’s website at www.kainoscapital.com.
About InterHealth Nutraceuticals, Inc.
InterHealth Nutraceuticals researches, develops, markets and distributes specialty nutritional ingredients, which are sold worldwide to manufacturers of dietary supplements and nutraceutical food and beverage products. The company’s products include UC-II® for addressing joint discomfort; Super CitriMax®, a weight loss and satiety ingredient; Meratrim® for weight management; and ChromeMate® and Zychrome® for blood sugar and insulin control. In addition, InterHealth offers LOWAT®, Aller-7®, OptiBerry®, L-OptiZinc®, Protykin® and ZMA®. For more information about InterHealth and its products, call 1-800-783-4636 or 1-707-751-2800 (outside U.S.) or visit www.interhealthusa.com.
About Deloitte Corporate Finance LLC
Deloitte Corporate Finance LLC, a FINRA-registered broker-dealer, is an indirect wholly-owned subsidiary of Deloitte Financial Advisory Services LLP and affiliate of Deloitte Transactions and Business Analytics LLP. Deloitte Corporate Finance LLC provides deal execution and lead financial advisory services to large corporate, middle market, and private equity firms. Deloitte Corporate Finance has access to the resources of the Corporate Finance Advisory practices of the member firms (and their affiliates) within the Deloitte Touche Tohmatsu Limited network of member firms. Together with Deloitte Corporate Finance LLC, these practices include in excess of 1,600 professionals, working collaboratively in 150 international locations. Investment banking products and services within the United States are offered exclusively through Deloitte Corporate Finance LLC. For more information, visit www.investmentbanking.deloitte.com. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries.
Prior engagement performance is no guarantee of future performance and may not be representative of the experience of other clients. This communication is for informational purposes only and is not intended as an offer or solicitation for the purchase or sale of a security.